LIVE

Serial Number

79334653

Owner

SYNthesis Research Pty Ltd

Filing Date

Sep 10, 2021

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

THE PHARM BIO Trademark

Serial Number: 79334653 • Registration: 7095416

THE PHARM BIO is a trademark filed by SYNthesis Research Pty Ltd on September 10, 2021. The trademark is classified under Class 36 (Insurance & Financial), Class 44 (Medical Services), Class 45 (Legal & Security Services). The application is currently registered and active.

Trademark Classes

Class 36 - Insurance & Financial

Insurance; financial affairs; monetary affairs; real estate affairs

Class 44 - Medical Services

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Class 45 - Legal & Security Services

Legal services; security services for the protection of property and individuals

Owner Contact Info

SYNthesis Research Pty Ltd

Bio21 Institute,

Entity Type: 82

The Pharm Bio Pty Ltd as trustee for ThePharm Bio Unit Trust (2 trademarks)

Bio21 Institute,
Parkville VIC 3052 , AU

Entity Type: 99

The Pharm Bio Pty Ltd as trustee for The (2 trademarks)

Bio21 Institute,
Parkville VIC 3052 , AU

Entity Type: 99

Legal Representation

Correspondence Address

Neil B Friedman Hodgson Russ LLP

605 Third Avenue

Suite 2300

New York

NY 10158

Trademark Details

Filing Date

September 10, 2021

Registration Date

July 4, 2023

Published for Opposition

April 11, 2023

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB

Nov 12, 2023 FINO

GENERIC MADRID TRANSACTION SENT TO IB

Oct 5, 2023 XXSS

GENERIC MADRID TRANSACTION CREATED

Oct 5, 2023 XXCR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

Oct 4, 2023 FICR

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Jul 4, 2023 NRCC

REGISTERED-PRINCIPAL REGISTER

Jul 4, 2023 R.PR

ELECTRONIC RECORD REVIEW COMPLETE

May 30, 2023 FIXD

ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED

May 26, 2023 ERRR

NOTIFICATION PROCESSED BY IB

Apr 24, 2023 GPNX

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Apr 11, 2023 NPUB

PUBLISHED FOR OPPOSITION

Apr 11, 2023 PUBO

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

Apr 5, 2023 OPNS

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

Apr 5, 2023 OP2R

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Mar 22, 2023 NONP

CHANGE OF OWNER RECEIVED FROM IB

Mar 18, 2023 CHLD

APPROVED FOR PUB - PRINCIPAL REGISTER

Mar 9, 2023 CNSA

EXAMINER'S AMENDMENT ENTERED

Mar 8, 2023 XAEC

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Mar 8, 2023 GNEN

EXAMINERS AMENDMENT E-MAILED

Mar 8, 2023 GNEA

EXAMINERS AMENDMENT -WRITTEN

Mar 8, 2023 CNEA

EXAMINER'S AMENDMENT ENTERED

Feb 23, 2023 XAEC

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Feb 23, 2023 GNEN

EXAMINERS AMENDMENT E-MAILED

Feb 23, 2023 GNEA

EXAMINERS AMENDMENT -WRITTEN

Feb 23, 2023 CNEA

TEAS/EMAIL CORRESPONDENCE ENTERED

Jan 28, 2023 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jan 27, 2023 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jan 27, 2023 TROA

REFUSAL PROCESSED BY IB

Aug 23, 2022 RFNP

NEW REPRESENTATIVE AT IB RECEIVED

Aug 15, 2022 NREP

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

Jul 29, 2022 RFCS

REFUSAL PROCESSED BY MPU

Jul 28, 2022 RFRR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Jul 7, 2022 RFCR

NON-FINAL ACTION WRITTEN

Jul 6, 2022 CNRT

ASSIGNED TO EXAMINER

Jun 15, 2022 DOCK

APPLICATION FILING RECEIPT MAILED

Apr 2, 2022 MAFR

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Mar 29, 2022 NWOS

LIMITATION FROM ORIGINAL APPLICATION ENTERED

Mar 14, 2022 LIMI

SN ASSIGNED FOR SECT 66A APPL FROM IB

Mar 3, 2022 REPR

Related Trademarks

More from this Owner

THE PHARM BIO

More in Same Class

METAFANS

POSITIVE CHANGE

GUEST INVEST

YOUR PRESCRIPTION FOR SUCCESS

THE PHARM BIO

NCD